Ningbo Menovo Pharmaceutical Co.,Ltd.’s Net Profit Dropped 83.2% in First Half of 2023

Ningbo Menovo Pharmaceutical Co.,Ltd. (宁波美诺华药业股份有限公司) (603538.SH) reported a net profit of 34.5 million yuan in the first half of 2023, down 83.2% year-on-year.

Meanwhile, the company posted 582.3 million yuan in revenue, down 35.1% year-on-year.

At the end of the reporting period, it had 4.3 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 49.5%.